Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David R Epstein
AddedMar 19, 2024
UpdatedMay 31, 2026
David R Epstein

David R Epstein

Board Member, Valo Health

CrunchbaseLinkedIn

David R Epstein's Career

Valo Health
Valo Health

Boston, MA, US

Board Member· Board
Seagen
Seagen

Bothell, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David R Epstein's Career

Valo Health
Valo Health
Series C$460M1682019Boston, MA, US
Board Member· Board

Leadership at Valo Health

David BerryDavid BerryFounder & CEO
Paul BiondiPaul BiondiBoard Member
Harsha RamalingamHarsha RamalingamBoard Member
Ron HovsepianRon HovsepianBoard Member
David BerryDavid BerryBoard Member
Adam SmalleyAdam SmalleyBoard Member

Similar to Valo Health

Valera HealthValera HealthNew York, USMental Health, Telehealthest. 2015Valera HealthNew York, US · est. 2015

Valera: A tech-driven tele-mental health firm, focusing on BIPOC and LGBTQ+ communities.

Series D · $71.9M344
Vesalius TherapeuticsVesalius TherapeuticsCambridge, MA, USDrug Developmentest. 2019Vesalius TherapeuticsCambridge, MA, US · est. 2019

Vesalius Therapeutics: Innovating drug development to combat major human illnesses.

Series A · $75M35
Valhalla HealthcareValhalla HealthcareHouston, TX, USHealthcareest. 2017Valhalla HealthcareHouston, TX, US · est. 2017

Healthcare tech firm using AI and ML to provide affordable, accessible, and effective care.

Seed · $100k6
Valorant HealthValorant HealthBerkeley, CA, USDigital Health, Healthcareest. 2019Valorant HealthBerkeley, CA, US · est. 2019

AI-enabled digital health system, bridging healthcare access for underserved US communities.

Pre-Seed · $1.3M14
Seagen
Seagen
Public$1.7B3.3k1997Bothell, WA, US
Board Member· Board

Leadership at Seagen

David GryskaDavid GryskaBoard Member
Clay SiegallClay SiegallFounder
Ted LoveTed LoveBoard Member
Felix BakerFelix BakerBoard Member
Daniel WelchDaniel WelchBoard Member

David R Epstein's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to David R Epstein

Armin KesslerArmin KesslerBoard Member · Gen-ProbeJeff McLarenJeff McLarenBoard Member · HealthStreamDaniel Haders II PhDDaniel Haders II PhDBoard Member · Model MedicinesDavid Richard HallDavid Richard HallFounder · Hall Venture PartnersRonald GoldRonald GoldBoard Member · NJ BioDavid MoskowitzDavid MoskowitzBoard Member · Appia Bio